Prednisone Completed Phase 2 Trials for Pulmonary Fibrosis / Chronic Lung Diseases / Sarcoidosis Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00000596Diffuse Fibrotic Lung Disease